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Several recent studies have demonstrated the potential of using continuous countercurrent tangential 
chromatography (CCTC) for the purification of monoclonal antibody products. CCTC operates with a flowing 
resin slurry, exploiting traditional approaches of countercurrent staging to achieve > 10-fold increases in 
productivity compared to traditional batch columns in a truly steady-state low pressure (<15 psi) unit operation 
that can be directly integrated into a fully continuous biomanufacturing process. The featured data shows 
productivity and product quality outcomes from Protein A capture, as well as Anion exchange and Cation 
exchange polishing steps for purification of a commercial mAb. Another unique aspect of CCTC is the ability to 
use small particle size resins with improved binding kinetics and better system productivity but without any 
increase in pressure. The data also features our strategy for integrating the unit operations into a single process 
train incorporating an integrated in-line sampling strategy. In addition we discuss the potential of this platform to 
enable efficient processing of sensitive biologics because of significantly reduced residence time (<10 min from 
binding to elution), as well as rapid in-line buffer adjustments of eluted product. 
